CX-2009
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CX-2009, covering 2024-01-05 to 2024-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer [Phase 2]